Tag Archives: INX-189

$INHX, inhibited?

So, what do you do if you want to get some exposure in the hot HCV space? A space where competition is steep and filled with big-time players such as Roche, JNJ (Tibotec), Bristol-Myers, Merck, Boehringer, and even Pharmasset at … Continue reading

Posted in Research | Tagged , , , , , , , , , , , , , | 2 Comments